The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice

Biogenetic and morphofunctional heterogeneity of mitochondria: the case of synaptic mitochondria

(2017) Sergei V. Fedorovich et al.   REVIEWS IN THE NEUROSCIENCES

The Effects of Astilbin on Cognitive Impairments in a Transgenic Mouse Model of Alzheimer’s Disease

(2016) Dongmei Wang et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer’s disease

(2016) Simon J. Beck et al.   Nature Communications

AMPK acts as a molecular trigger to coordinate glutamatergic signals and adaptive behaviours during acute starvation

(2016) Moloud Ahmadi et al.   eLife

Role of Mitochondria in Neurodegenerative Diseases: Mitochondria as a Therapeutic Target in Alzheimer's Disease

(2016) P. Hemachandra Reddy   CNS SPECTRUMS

Altered brain energetics induces mitochondrial fission arrest in Alzheimer’s Disease

(2016) Liang Zhang et al.   Scientific Reports

Cardiotrophin-1 (CT-1) Improves High Fat Diet-Induced Cognitive Deficits in Mice

(2015) Dongmei Wang et al.   NEUROCHEMICAL RESEARCH

Resveratrol up-regulates AMPA receptor expression via AMP-activated protein kinase-mediated protein translation

(2015) Guan Wang et al.   NEUROPHARMACOLOGY

Hesperidin Alleviates Cognitive Impairment, Mitochondrial Dysfunction and Oxidative Stress in a Mouse Model of Alzheimer’s Disease

(2014) Dongmei Wang et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Effects of Long-Term Treatment with Quercetin on Cognition and Mitochondrial Function in a Mouse Model of Alzheimer’s Disease

(2014) Dong-Mei Wang et al.   NEUROCHEMICAL RESEARCH

Red ginseng abrogates oxidative stress via mitochondria protection mediated by LKB1-AMPK pathway

(2013) Guang-Zhi Dong et al.   BMC Complementary and Alternative Medicine

Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation

(2013) David Castaño et al.   JOURNAL OF HEPATOLOGY

Protective Effects of Hesperidin Against Amyloid-β (Aβ) Induced Neurotoxicity Through the Voltage Dependent Anion Channel 1 (VDAC1)-Mediated Mitochondrial Apoptotic Pathway in PC12 Cells

(2013) Dong-Mei Wang et al.   NEUROCHEMICAL RESEARCH

Cardiotrophin-1 (CTF1) ameliorates glucose-uptake defects and improves memory and learning deficits in a transgenic mouse model of Alzheimer's disease

(2013) Dongmei Wang et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Bmf upregulation through the AMP-activated protein kinase pathway may protect the brain from seizure-induced cell death

(2013) C Moran et al.   Cell Death & Disease

α-SNAP inhibits AMPK signaling to reduce mitochondrial biogenesis and dephosphorylates Thr172 in AMPKα in vitro

(2013) Lifu Wang et al.   Nature Communications

Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage

(2012) M. Manczak et al.   HUMAN MOLECULAR GENETICS

Dual effect of the heart-targeting cytokine cardiotrophin-1 on glucose transport in cardiomyocytes

(2012) Mohamed Asrih et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

AMP Kinase Activation Mitigates Dopaminergic Dysfunction and Mitochondrial Abnormalities in Drosophila Models of Parkinson's Disease

(2012) C.-H. Ng et al.   JOURNAL OF NEUROSCIENCE

Defective Leptin–AMP-Dependent Kinase Pathway Induces Nitric Oxide Release and Contributes to Mitochondrial Dysfunction and Obesity in ob/ob Mice

(2011) Paola V. Finocchietto et al.   ANTIOXIDANTS & REDOX SIGNALING

Synaptic Mitochondrial Pathology in Alzheimer's Disease

(2011) Heng Du et al.   ANTIOXIDANTS & REDOX SIGNALING

Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease

(2011) Wei Zhang et al.   BEHAVIOURAL BRAIN RESEARCH

AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer

(2011) D. Grahame Hardie   BIOCHEMICAL SOCIETY TRANSACTIONS

Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: Implications to mitochondria-targeted antioxidant therapeutics

(2011) P. Hemachandra Reddy et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Cardiotrophin-1 Is a Key Regulator of Glucose and Lipid Metabolism

(2011) María J. Moreno-Aliaga et al.   Cell Metabolism

Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage

(2011) Maria Manczak et al.   HUMAN MOLECULAR GENETICS

Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease

(2011) M. J. Calkins et al.   HUMAN MOLECULAR GENETICS

Loss of activity-induced phosphorylation of MeCP2 enhances synaptogenesis, LTP and spatial memory

(2011) Hongda Li et al.   NATURE NEUROSCIENCE

miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor

(2010) Hailin Wang et al.   BRAIN RESEARCH

Unraveling Mechanisms of Homeostatic Synaptic Plasticity

(2010) Karine Pozo et al.   NEURON

Metabolic Regulation of Neuronal Plasticity by the Energy Sensor AMPK

(2010) Wyatt B. Potter et al.   PLoS One

Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model

(2010) H. Du et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Spatial navigation testing discriminates two types of amnestic mild cognitive impairment

(2009) Jan Laczó et al.   BEHAVIOURAL BRAIN RESEARCH

AMPK-mediated GSK3β inhibition by isoliquiritigenin contributes to protecting mitochondria against iron-catalyzed oxidative stress

(2009) Song Hwa Choi et al.   BIOCHEMICAL PHARMACOLOGY

Mitochondria: A therapeutic target in neurodegeneration

(2009) Paula I. Moreira et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Resveratrol Protects Mitochondria against Oxidative Stress through AMP-Activated Protein Kinase-Mediated Glycogen Synthase Kinase-3  Inhibition Downstream of Poly(ADP-ribose)polymerase-LKB1 Pathway

(2009) S. M. Shin et al.   MOLECULAR PHARMACOLOGY

Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

(2009) J. Yao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease

(2008) Heng Du et al.   NATURE MEDICINE

Amyloid-  overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins

(2008) X. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Animal models of neonatal stroke and response to erythropoietin and cardiotrophin-1

(2007) Augusto Sola et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE